山东华特达因健康股份有限公司 第十一届董事会2025年第五次临时 会议决议公告

Group 1 - The company held its fifth temporary board meeting of the 11th session on December 22, 2025, with all 9 directors present, confirming compliance with legal and regulatory requirements [2] - The board approved several proposals unanimously, including amendments to the General Manager's Office Meeting Rules, the Board Secretary Work System, and the Information Disclosure Management System [3][4] - The board also approved the establishment of a temporary and exemption management system for information disclosure and agreed to extend the operational period of the Everbright Wealth Medical Fund until January 30, 2028, along with signing a supplementary agreement [4]